Correction: CRISPR/Cas9-edited NSG mice as PDX models of human leukemia to address the role of niche-derived SPARC

Leukemia volume 35, page294(2021)Cite this article

The Original Article was published on 06 December 2017

Download PDF

Correction to: Leukemia

https://doi.org/10.1038/leu.2017.346

This article was originally published under NPG’s License to Publish, but has now been made available under a CCBY license. The PDF and HTML versions of the paper have been modified accordingly.

Author information

Author notes

  1. These authors contributed equally: I Tirado-Gonzalez, E Czlonka, A Nevmerzhitskaya

Affiliations

  1. Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany

    I. Tirado-Gonzalez, E. Czlonka, A. Nevmerzhitskaya, D. Soetopo, E. Bergonzani, A. Mahmoud, A. Contreras & H. Medyouf

  2. Department of Apoptosis in Hematopoietic Stem Cells, Helmholtz Center Münich, German Center for Environmental Health (HMGU), Munich, Germany

    I. Jeremias

  3. German Cancer Consortium, DKTK Partner Site Munich, Heidelberg, Germany

    I. Jeremias

  4. University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany

    U. Platzbecker

  5. German Cancer Consortium, DKTK Partner Site Dresden, Heidelberg, Germany

    U. Platzbecker

  6. Division of Pediatric Oncology, University Children’s Hospital, Zurich, Switzerland

    J. P. Bourquin & U. Kloz

  7. Transgenic Service, German Cancer Research Center, Heidelberg, Germany

    F. Van der Hoeven

  8. German Cancer Consortium, DKTK Partner Site Frankfurt/Mainz, Heidelberg, Germany

    H. Medyouf

  9. Department of Hematology and Oncology, University Hospital Mannheim, Medical Faculty, University of Heidelberg, Mannheim, Germany

    H. Medyouf

Authors
  1. I. Tirado-Gonzalez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Czlonka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Nevmerzhitskaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Soetopo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. Bergonzani
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Mahmoud
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. Contreras
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. I. Jeremias
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. U. Platzbecker
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. J. P. Bourquin
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. U. Kloz
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. F. Van der Hoeven
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. H. Medyouf
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. Medyouf.

Additional information

The original article can be found online at https://doi.org/10.1038/leu.2017.346.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Tirado-Gonzalez, I., Czlonka, E., Nevmerzhitskaya, A. et al. Correction: CRISPR/Cas9-edited NSG mice as PDX models of human leukemia to address the role of niche-derived SPARC. Leukemia 35, 294 (2021). https://doi.org/10.1038/s41375-020-01071-7

Download citation

Search

Quick links